开发和实施口服抗癌剂工具,用于主题质量改善计划:血液病瘤学药剂师协会与ASCO质量培训计划之间的合作
Victoria Nachar1,2, Marjorie Adams Curry3, Diana Kostoff4
1University of Michigan Rogel Cancer Center, Ann Arbor, MI.
JCO oncology practice
|January 23, 2025
概括
标准化口服抗癌剂 (OAA) 工具可以改善OAA管理和患者护理. 这些工具有助于识别和克服OAA服务交付中的障碍,以实现更好的质量改进计划.
科学领域:
- 瘤学 药房 实践
- 提高医疗保健的质量 改善医疗保健的质量
- 口服抗癌药物管理管理
背景情况:
- 口服抗癌剂 (OAAs) 需要强大的管理计划,以获得最佳的患者结果.
- 血液学瘤学药剂师协会口服化疗协作 (HOPA OCC) 确定在OAA管理中需要标准化工具.
- 现有的OAA项目在提供服务方面经常面临挑战.
研究的目的:
- 开发和评估基于实践的工具,以加强口服抗癌剂 (OAA) 计划的开发和改进.
- 评估这些工具在识别和解决OAA服务交付障碍方面的有用性.
主要方法:
- 开发一个基线OAA程序评估,临床OAA坚持工具和OAA仪表板.
- 将工具分发给HOPA ASCO质量培训计划 (QTP) 的团队.
- 评估跨领域的障碍,包括副作用监测,坚持,患者报告的结果,健康的社会决定因素和协作实践.
主要成果:
- 确定的实施障碍包括信息技术缺口,资源限制和竞争优先事项.
- 这些工具为评估OAA计划的优点和弱点提供了一个框架.
- 用参与者的反来评估工具的实用性.
结论:
- 标准化的OAA管理工具在告知和支持质量改善举措方面是有效的.
- 这些工具的实施可以改善接受口服抗癌剂的患者的护理.
- 解决已识别的障碍对于成功增强OAA计划至关重要.
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Cancer Survival Analysis
327
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
327


